Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.

R J MacFadyen, K R Lees, J L Reid

University Department of Medicine and Therapeutics, University of Glasgow.

OBJECTIVE--To compare the first dose responses to low dose angiotensin converting enzyme inhibitors (captopril, enalapril, and perindopril) in elderly patients with stable chronic heart failure. DESIGN--Double blind, randomised, placebo controlled, parallel, group prospective study of elderly patients with stable chronic heart failure. SETTING--General hospital in-patient admissions for supervised diuretic withdrawal (24-48 hours) and the introduction of angiotensin converting enzyme inhibitor therapy. PATIENTS--48 unselected elderly (58-85 years) patients with symptomatic but stable chronic heart failure (New York Heart Association grades II-IV) confirmed by clinical history, examination, and cardiological investigations. Patients gave their written and informed consent to receive their initial treatment under double blind conditions; blood pressure was monitored and blood samples taken to measure the pharmacokinetic and neurohormonal responses. INTERVENTION--Patients were randomised to receive a daily oral dose of placebo, captopril (6.25 mg), enalapril (2.5 mg), or perindopril (2 mg). MAIN OUTCOME MEASURES--Blood pressure and heart rate responses, drug concentration, and plasma renin and ACE activities. Differences between treatment groups were analysed by analysis of variance. RESULTS--The four randomised groups of patients had similar age, severity of heart failure (NYHA class), pretreatment diuretic dosage, plasma renin activity, and serum electrolyte state. Placebo treatment caused a modest but significant diurnal fall in blood pressure. Captopril produced a significant early (1.5 hours) and brief fall in blood pressure. The blood pressure fall with enalapril was later (4-10 hours), longer lasting, and was associated with significant slowing of supine heart rate. Though perindopril produced a similar plasma ACE inhibition to that produced by enalapril, it only caused changes in blood pressure that were similar to those caused by placebo. CONCLUSIONS--This controlled study is the first to indicate a qualitative difference in the acute response to angiotensin converting enzyme inhibitors with similar structure and metabolism (that is, enalapril and perindopril). Low dose perindopril seems to be less likely to cause hypotension in patients with heart failure. The explanation for the differences is unclear but may reflect differential effects on local tissue angiotensin generation.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Fox, K. (2008). Benefits of perindopril all along the cardiovascular continuum: the level of evidence. Eur Heart J Suppl 10: G4-G12 [Abstract] [Full Text]  
• Kao, C.-D., Chang, J.-B., Chen, J.-T., Wu, Z.-A., Shan, D.-E, Liao, K.-K. (2004). Hypotension Due to Interaction Between Lisinopril and Tizanidine. The Annals of Pharmacotherapy 38: 1840-1843 [Abstract] [Full Text]  
• Bertrand, M.E., Bassand, J.-P. (2003). New evidence for angiotensin-converting enzyme inhibition in stroke, cardiac and renal patients: the cardiological approach. Eur Heart J Suppl 5: E1-E3  
• Walters, M. R., Bolster, A., Dyker, A. G., Lees, K. R. (2001). Effect of Perindopril on Cerebral and Renal Perfusion in Stroke Patients With Carotid Disease. Stroke 32: 473-478 [Abstract] [Full Text]  
• Vitovec, J., Spinar, J., Czech and Slovak Investigator Group, (2000). First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Eur J Heart Fail 2: 299-304 [Abstract] [Full Text]  
• Squire, I. B., O'Kane, K. P. J., Anderson, N., Reid, J. L. (2000). Bradykinin B2 Receptor Antagonism Attenuates Blood Pressure Response to Acute Angiotensin-Converting Enzyme Inhibition in Normal Men. Hypertension 36: 132-136 [Abstract] [Full Text]  
• Cleland, J. G.F., Tendera, M., Adamus, J., Freemantle, N., Gray, C. S., Lye, M., O'Mahony, D., Polonski, L., Taylor, J., PEP investigators, (1999). Perindopril for elderly people with chronic heart failure: the PEP-CHF study. Eur J Heart Fail 1: 211-217 [Abstract] [Full Text]  
• Dyker, A. G., Grosset, D. G., Lees, K. (1997). Perindopril Reduces Blood Pressure but Not Cerebral Blood Flow in Patients With Recent Cerebral Ischemic Stroke. Stroke 28: 580-583 [Abstract] [Full Text]